Within CD4+CD25high cells, the fraction of FoxP3+ CD39+ identified with clone 150D was significantly lower in MS patients compared to healthy donors; staining with the other antibody clones revealed lower frequencies of CD39+FoxP3+ cells in MS patients, although statistical significance was not reached. This evidence concerns the gene CD4 and myeloid sarcoma.